Inactive Instrument
Phosphagenics Limited Stock Australian S.E.
Stocks
AU000000POH7
Pharmaceuticals
OTC Markets Traded| Market Cap | 57.46M 40.28M 35.12M 32.53M 30.45M 57.11M 3.8B 386M 150M 1.87B 151M 148M 6.5B | P/E 2024 |
-2.5x | P/E 2025 | -6.43x |
|---|---|---|---|---|---|
| Enterprise Value | 52.81M 37.02M 32.28M 29.9M 27.99M 52.49M 3.49B 355M 137M 1.72B 139M 136M 5.97B | EV / Sales 2024 |
5.85x | EV / Sales 2025 | 23x |
| Free-Float |
75.85% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -14.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul David Gavin
CEO | Chief Executive Officer | - | 2020-04-30 |
Roksan Libinaki
COO | Chief Operating Officer | - | 2020-04-30 |
Naomi Lawrie
SEC | Corporate Secretary | - | 2026-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Murdoch
BRD | Director/Board Member | - | 2015-04-12 |
Gregory Collier
CHM | Chairman | - | 2018-12-31 |
Kathy Connell
BRD | Director/Board Member | 59 | 2024-04-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -14.29% | -14.29% | - | - | 40.28M | ||
| +0.07% | -2.48% | +42.91% | +140.63% | 980B | ||
| +0.91% | -2.53% | +51.80% | +38.69% | 550B | ||
| +5.57% | +2.54% | +23.65% | +65.36% | 382B | ||
| -0.27% | -3.09% | +23.33% | +16.78% | 316B | ||
| +0.29% | +0.46% | +27.26% | +14.32% | 272B | ||
| +1.34% | -0.43% | +25.89% | +32.91% | 268B | ||
| +2.05% | +4.13% | -34.01% | -45.23% | 199B | ||
| +1.30% | -2.42% | +25.54% | +48.93% | 182B | ||
| 0.00% | -0.45% | +16.53% | +58.42% | 154B | ||
| Average | -0.29% | -2.70% | +22.55% | +41.20% | 366.93B | |
| Weighted average by Cap. | +1.14% | -3.50% | +30.80% | +63.88% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.13M 794K 692K 641K 600K 1.13M 74.93M 7.61M 2.95M 36.88M 2.98M 2.92M 128M | 1.24M 868K 757K 701K 656K 1.23M 81.88M 8.31M 3.22M 40.3M 3.26M 3.19M 140M |
| Net income | -3.12M -2.19M -1.91M -1.77M -1.65M -3.1M -207M -20.97M -8.13M -102M -8.22M -8.04M -353M | -4.42M -3.1M -2.7M -2.5M -2.34M -4.39M -292M -29.66M -11.5M -144M -11.62M -11.37M -499M |
| Net Debt | -1.3M -910K -793K -735K -688K -1.29M -85.86M -8.72M -3.38M -42.26M -3.42M -3.34M -147M | -4.65M -3.26M -2.84M -2.63M -2.46M -4.62M -308M -31.23M -12.1M -151M -12.24M -11.97M -526M |
Employees
-
Sector
Pharmaceuticals
















